Dupixent on SilverScript Choice (S5601-032)
dupilumab
Covered, with prior authorization required.
Tier 5 (specialty tier). Quantity limit of 4.56 per 28 days.
$2,262.03
Patient pays / month, after deductible
$2,723.28
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
DUPIXENT 200 mg/1.14mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $9,048.12 for a month. Other covered strengths are listed below.
Prior authRequired on all 4 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 4 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| DUPIXENT 300 mg/2mL Injection, Solution | 5 | $2,321.17 | PA · 8 per 28 days |
| DUPIXENT 300 mg/2mL Injection, Solution | 5 | $2,320.85 | PA · 8 per 28 days |
| DUPIXENT 200 mg/1.14mL Injection, Solution | 5 | $2,262.03 | PA · 4.56 per 28 days |
| DUPIXENT 200 mg/1.14mL Injection, Solution | 5 | $2,262.03 | PA · 4.56 per 28 days |
Other Asthma and COPD biologics on this plan
Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5601-032